Literature DB >> 25953588

Molecular basis for D- Japanese: identification of novel DEL and D- alleles.

K Ogasawara1, Y Suzuki2, K Sasaki1, T Osabe2, K Isa1, H Tsuneyama2, M Uchikawa2, M Satake1, K Tadokoro1.   

Abstract

BACKGROUND AND OBJECTIVES: The occurrence of D- is approximately 0.5% in Japanese, but DEL in apparently D- individuals is relatively common compared with that in Caucasian populations. On the basis of molecular genetics, we examined D- Japanese blood donors.
METHODS: A standard serological technique was used for RhD typing, and we selected 3526 D- blood samples. Genomic DNA obtained from whole blood was used for RHD analysis by polymerase chain reaction (PCR) and sequencing. Multiplex PCR to detect all of the RHD exons and use of PCR-sequence-specific primer (PCR-SSP) to detect RHD deletion (RHD*01N.01) and c.1227G>A mutation (for RHD*01EL.01) were performed.
RESULTS: Multiplex PCR and PCR-SSP revealed that 3091 of 3526 D- individuals (87.7%) were homozygous for RHD*01N.01, and 318 individuals (9.0%) had the RHD*01EL.01/RHD*01N.01 or RHD*01EL.01/RHD*01EL.01 genotype. The other 103 in the 3526 individuals (2.9%) had the known D-CE-D hybrid allele, RHD*01N.04, and the association of RHCE*Ce with RHD*01EL.01 as well as RHD*01N.04 was observed. The remaining 14 individuals had RHD*01N.01 hemizygous with one of the following alleles: RHD*01N.06 (3), RHD*01N.07 (1), RHD*04N.01 (1), RHD*DEL8 (1), RHD with c.761C>G (p.Ser254Ter) (2), RHD with c.1252T>A (p.Ter418Lysex26) (2) and apparently common RHD (4). Adsorption and elution tests with anti-D revealed that the individuals with c.761C>G mutation were D- while the individuals with c.1252T>A mutation were DEL.
CONCLUSIONS: The RHD genotype of more than 96% of D- Japanese could be determined by conventional PCR-SSP. In addition, we identified a novel DEL allele having c.1252T>A mutation and a novel RHD silencing allele having c.761C>G nonsense mutation.
© 2015 International Society of Blood Transfusion.

Entities:  

Keywords:  DEL; D− Japanese; RHD gene

Mesh:

Substances:

Year:  2015        PMID: 25953588     DOI: 10.1111/vox.12290

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  8 in total

1.  [Genotyping of RhD-negative blood samples diagnosed by serological tests from patients waiting for kidney transplantation].

Authors:  Shao-Jie Fu; Yan-Lin Feng; Li-Xin Yu; Yun Miao; Min Luo; Yi-Bin Wang; Yi-Chen Li; Shu-Han Chen; Lu-Lu Xiao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-06-20

2.  DEL.

Authors:  Willy Albert Flegel; Franz Friedrich Wagner
Journal:  Blood Transfus       Date:  2020-03-17       Impact factor: 3.443

3.  DEL phenotype.

Authors:  Dong H Kwon; S G Sandler; Willy A Flegel
Journal:  Immunohematology       Date:  2017-09

4.  A practical and effective strategy in East Asia to prevent anti-D alloimmunization in patients by C/c phenotyping of serologic RhD-negative blood donors.

Authors:  Shoichi Ito; Hitoshi Ohto; Yoshiko Ogiyama; Michiyo Irino; Susumu Omokawa; Itaru Shibasaki; Kenichi Ogasawara; Makoto Uchikawa; Kenneth E Nollet; Willy A Flegel
Journal:  EJHaem       Date:  2021-09-16

5.  RHD-Positive Alleles among D- C/E+ Individuals from India.

Authors:  Swati S Kulkarni; Harita Gogri; Disha Parchure; Garima Mishra; Kanjaksha Ghosh; Sunil Rajadhyaksha; Manisha Madkaikar; Claude Férec; Yann Fichou
Journal:  Transfus Med Hemother       Date:  2018-01-10       Impact factor: 3.747

Review 6.  Frameshift variations in the RHD coding sequence: Molecular mechanisms permitting protein expression.

Authors:  Willy A Flegel; Kshitij Srivastava
Journal:  Transfusion       Date:  2020-10-09       Impact factor: 3.337

7.  Weak D Testing is not Required for D- Patients With C-E- Phenotype.

Authors:  Sooin Choi; Sejong Chun; Hwan Tae Lee; HongBi Yu; Ji Young Seo; Duck Cho
Journal:  Ann Lab Med       Date:  2018-11       Impact factor: 3.464

Review 8.  DEL in China: the D antigen among serologic RhD-negative individuals.

Authors:  Qinan Yin; Willy Albert Flegel
Journal:  J Transl Med       Date:  2021-10-20       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.